The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 05, 1999

Filed:

Apr. 24, 1996
Applicant:
Inventors:

Toshiro Shimamura, Kawasaki, JP;

Junji Hamuro, Kawasaki, JP;

Harumi Nakazawa, Kawasaki, JP;

Yuka Kanayama, Kawasaki, JP;

Kazuo Sugamura, Sendi, JP;

Toshikazu Takeshita, Sendi, JP;

Assignees:

Ajinomoto Co., Inc., Tokyo, JP;

Kazuo Sugamura, Sendai, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12P / ; C12P / ; C12N / ; C12N / ;
U.S. Cl.
CPC ...
435 6952 ; 435 691 ; 4352523 ; 4353201 ; 435239 ; 536 2353 ; 536 235 ; 53038822 ;
Abstract

A polypeptide which specifically binds to the .gamma.-chain of the human interleukin-2 receptor and selectively inhibits the binding of the .gamma.-chain of human interleukin-2 receptor to the .beta.-chain of the same is provided. The polypeptide has an activity of blocking the human interleukin-2 response. Also provided are an immunosuppressant containing the polypeptide, a DNA gene coding for the polypeptide, a recombinant DNA having the gene, a transformant having the recombinant DNA, and a method for producing the intended polypeptide by incubating the transformant. The novel polypeptide can be used independently, or with substances capable of inhibiting the binding of interleukin-2 to the interleukin-2 receptor, as a medicine for preventing the rejection of grafts after transplantation and also for curing inflammatory diseases such as allergic diseases and autoimmune diseases.


Find Patent Forward Citations

Loading…